LSP4-2022 [Ligand Id: 6706] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL3114673
  • mGlu4 receptor/Metabotropic glutamate receptor 4 in Human [ChEMBL: CHEMBL2736] [GtoPdb: 292] [UniProtKB: Q14833]
  • mGlu4 receptor/Metabotropic glutamate receptor 4 in Rat [ChEMBL: CHEMBL2787] [GtoPdb: 292] [UniProtKB: P31423]
There should be some charts here, you may need to enable JavaScript!
  • mGlu6 receptor/Metabotropic glutamate receptor 6 in Human [ChEMBL: CHEMBL4573] [GtoPdb: 294] [UniProtKB: O15303]
  • mGlu6 receptor/Metabotropic glutamate receptor 6 in Rat [ChEMBL: CHEMBL3842] [GtoPdb: 294] [UniProtKB: P35349]
There should be some charts here, you may need to enable JavaScript!
  • mGlu7 receptor in Human [GtoPdb: 295] [UniProtKB: Q14831]
  • mGlu7 receptor/Metabotropic glutamate receptor 7 in Rat [ChEMBL: CHEMBL3879] [GtoPdb: 295] [UniProtKB: P35400]
There should be some charts here, you may need to enable JavaScript!
  • mGlu8 receptor/Metabotropic glutamate receptor 8 in Human [ChEMBL: CHEMBL3228] [GtoPdb: 296] [UniProtKB: O00222]
  • mGlu8 receptor/Metabotropic glutamate receptor 8 in Rat [ChEMBL: CHEMBL2718] [GtoPdb: 296] [UniProtKB: P70579]
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
mGlu4 receptor/Metabotropic glutamate receptor 4 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2736] [GtoPdb: 292] [UniProtKB: Q14833]
ChEMBL Agonist activity at mGlu4 (unknown origin) expressed in HEK293 cells coexpressing chimeric Gq/i protein assessed as increase in intracellular calcium accumulation by Fluo-4 AM dye based fluorescence assay F 6.96 pEC50 110 nM EC50 J Med Chem (2018) 61: 1969-1989 [PMID:29397723]
GtoPdb - - 6.96 pEC50 110 nM EC50 FASEB J (2012) 26: 1682-93 [PMID:22223752]
mGlu4 receptor/Metabotropic glutamate receptor 4 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2787] [GtoPdb: 292] [UniProtKB: P31423]
ChEMBL Agonist activity against rat mGlu4 S160A mutant B 4.58 pEC50 26200 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Agonist activity against rat mGlu4 S160D mutant B 4.73 pEC50 18500 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Agonist activity against rat mGlu4 R60A mutant B 5.04 pEC50 9070 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Agonist activity at rat mGlu4 R258A mutant B 5.31 pEC50 4910 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Agonist activity against wild type rat mGlu4 F 6.08 pEC50 833 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Pharmacological Assay: Metabotropic glutamate receptors were transiently transfected in HEK293 cells by electroporation as described elsewhere (Brabet I. et al., 1998) and plated in 96-well microplates. The high affinity glutamate transporter EAAC1 was co-transfected with the receptor in order to avoid any influence of glutamate released by the cells in the assay medium. In the experiments carried out by the inventors, Group-III mGluRs were co-transfected with a chimeric G-protein which couples the activation of the receptor to the phospholipase-C (PLC) pathway. Thus receptor activation induces production of inositol phosphate (IP) which in turn induces intracellular Ca2+ release. Receptor activity was then determined by measurement of the IP production or Ca release as already described (Goudet C. et al., PNAS 2004). For intracellular calcium measurements, cells expressing mGluRs were loaded with Ca2+-sensitive fluorescent dye Fluo-4 AM (Invitrogen, Cergy-Pontoise, France) dissolved in Hanks' balanced Salt Solution. F 6.96 pEC50 110 nM EC50 US-9212196-B2. Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof (2015)
ChEMBL Agonist activity against rat mGlu4 K74A mutant B 7.62 pEC50 24 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
mGlu6 receptor/Metabotropic glutamate receptor 6 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4573] [GtoPdb: 294] [UniProtKB: O15303]
GtoPdb - - 5.36 pEC50 4400 nM EC50 FASEB J (2012) 26: 1682-93 [PMID:22223752]
ChEMBL Agonist activity at mGlu6 (unknown origin) expressed in HEK293 cells coexpressing chimeric Gq/i protein assessed as increase in intracellular calcium accumulation by Fluo-4 AM dye based fluorescence assay F 5.38 pEC50 4200 nM EC50 J Med Chem (2018) 61: 1969-1989 [PMID:29397723]
mGlu6 receptor/Metabotropic glutamate receptor 6 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3842] [GtoPdb: 294] [UniProtKB: P35349]
ChEMBL Pharmacological Assay: Metabotropic glutamate receptors were transiently transfected in HEK293 cells by electroporation as described elsewhere (Brabet I. et al., 1998) and plated in 96-well microplates. The high affinity glutamate transporter EAAC1 was co-transfected with the receptor in order to avoid any influence of glutamate released by the cells in the assay medium. In the experiments carried out by the inventors, Group-III mGluRs were co-transfected with a chimeric G-protein which couples the activation of the receptor to the phospholipase-C (PLC) pathway. Thus receptor activation induces production of inositol phosphate (IP) which in turn induces intracellular Ca2+ release. Receptor activity was then determined by measurement of the IP production or Ca release as already described (Goudet C. et al., PNAS 2004). For intracellular calcium measurements, cells expressing mGluRs were loaded with Ca2+-sensitive fluorescent dye Fluo-4 AM (Invitrogen, Cergy-Pontoise, France) dissolved in Hanks' balanced Salt Solution. F 5.38 pEC50 4200 nM EC50 US-9212196-B2. Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof (2015)
mGlu7 receptor in Human [GtoPdb: 295] [UniProtKB: Q14831]
GtoPdb - - 4.94 pEC50 11600 nM EC50 FASEB J (2012) 26: 1682-93 [PMID:22223752]
mGlu7 receptor/Metabotropic glutamate receptor 7 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3879] [GtoPdb: 295] [UniProtKB: P35400]
ChEMBL Agonist activity at rat mGlu7 N74K mutant B 4.33 pEC50 47000 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Agonist activity at rat mGlu7 N74A mutant B 4.49 pEC50 32000 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Agonist activity at wild type rat mGlu7 F 4.67 pEC50 21379.62 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Agonist activity at wild type rat mGlu7 F 4.67 pEC50 21200 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Antagonist activity against LSP4-202-induced rat mGlu7 activation transfected in HEK293 cells co-transfected with chimeric Gqi9 assessed as decrease in LSP4-202 potency by measuring LSP4-202 pEC50 incubated for 24 hrs by IP-one HTRF assay F 4.71 pEC50 19498.45 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Agonist activity at rat mGlu7 Q258A mutant B 4.74 pEC50 18200 nM EC50 J Med Chem (2024) 67: 11662-11687 [PMID:38691510]
ChEMBL Pharmacological Assay: Metabotropic glutamate receptors were transiently transfected in HEK293 cells by electroporation as described elsewhere (Brabet I. et al., 1998) and plated in 96-well microplates. The high affinity glutamate transporter EAAC1 was co-transfected with the receptor in order to avoid any influence of glutamate released by the cells in the assay medium. In the experiments carried out by the inventors, Group-III mGluRs were co-transfected with a chimeric G-protein which couples the activation of the receptor to the phospholipase-C (PLC) pathway. Thus receptor activation induces production of inositol phosphate (IP) which in turn induces intracellular Ca2+ release. Receptor activity was then determined by measurement of the IP production or Ca release as already described (Goudet C. et al., PNAS 2004). For intracellular calcium measurements, cells expressing mGluRs were loaded with Ca2+-sensitive fluorescent dye Fluo-4 AM (Invitrogen, Cergy-Pontoise, France) dissolved in Hanks' balanced Salt Solution. F 4.94 pEC50 11600 nM EC50 US-9212196-B2. Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof (2015)
mGlu8 receptor/Metabotropic glutamate receptor 8 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3228] [GtoPdb: 296] [UniProtKB: O00222]
ChEMBL Agonist activity at mGlu8 (unknown origin) expressed in HEK293 cells coexpressing chimeric Gq/i protein assessed as increase in intracellular calcium accumulation by Fluo-4 AM dye based fluorescence assay F 4.53 pEC50 29200 nM EC50 J Med Chem (2018) 61: 1969-1989 [PMID:29397723]
mGlu8 receptor/Metabotropic glutamate receptor 8 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2718] [GtoPdb: 296] [UniProtKB: P70579]
ChEMBL Pharmacological Assay: Metabotropic glutamate receptors were transiently transfected in HEK293 cells by electroporation as described elsewhere (Brabet I. et al., 1998) and plated in 96-well microplates. The high affinity glutamate transporter EAAC1 was co-transfected with the receptor in order to avoid any influence of glutamate released by the cells in the assay medium. In the experiments carried out by the inventors, Group-III mGluRs were co-transfected with a chimeric G-protein which couples the activation of the receptor to the phospholipase-C (PLC) pathway. Thus receptor activation induces production of inositol phosphate (IP) which in turn induces intracellular Ca2+ release. Receptor activity was then determined by measurement of the IP production or Ca release as already described (Goudet C. et al., PNAS 2004). For intracellular calcium measurements, cells expressing mGluRs were loaded with Ca2+-sensitive fluorescent dye Fluo-4 AM (Invitrogen, Cergy-Pontoise, France) dissolved in Hanks' balanced Salt Solution. F 4.53 pEC50 29200 nM EC50 US-9212196-B2. Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof (2015)

ChEMBL data shown on this page come from version 36:

Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]